ArticleCancer chemotherapy and pharmacology2026

A novel cabozantinib formulation with improved safety and bioavailability: preclinical validation in rats.

Shangwei Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.